Grand Serology ELISA: Analytical Validation (Mt Sinai)
BRD ID: 3,106
Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 20
Description
This assay analytical validation and performance report describes the methods used to validate a standard enzyme-linked immunosorbent assay (ELISA) and grand serology assay for multiple antigens to assess a patient's serological repertoire using plasma and serum from peripheral blood and bone marrow. The document also presents data supporting the reported accuracy, precision, analytical sensitivity and specificity, and cross-site harmonization. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at Mount Sinai. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm), a Cancer Moonshot Initiative.
Documents for Download
Analytical report_Grand serology ELISA_07252019_Mt Sinai_508_Final.pdf [Size: 2142 KB]Biospecimens
- Fluid - Blood
- Fluid - Plasma
- Fluid - Serum
- Fluid - Bone Marrow
Diagnoses
- General
- Neoplastic - Melanoma
- Neoplastic - Carcinoma
- Normal
Topics
- Biospecimen Acquisition
- Biospecimen Processing
- Storage
- Platform-specific Methodology
Associated SOP Compendiums
- Biospecimen Acquisition
- Biospecimen Processing
- Storage
- Platform-specific Methodology